Most of these services are fine. A few are genuinely good. One or two are overpriced for what you get.
I went through the pricing, pharmacy details, and monitoring setups for every major GLP-1 telehealth option I could find. What kept coming up in forums, Reddit threads, and patient Facebook groups was a short list of recurring complaints: surprise fees, unnamed compounding labs, and doctors who rubber-stamp prescriptions without any real follow-up. The programs below mostly avoid those problems. Not all of them are cheap. Not all of them are for everyone. But they’re the ones worth your time in 2026.
1. HealthRX
The single fact that puts HealthRX at the top of this list: compounded semaglutide from $99 a month, compounded tirzepatide from $149, with free overnight shipping to all 50 states and a named, traceable pharmacy behind every order. That pharmacy is Manifest Pharmacy in Greer, South Carolina, a 503A/USP-797 compounding facility with lot-level tracking and LegitScript certification (cert 50087439). You’re not trusting an anonymous lab. The physician review runs about 24 hours. Those prices genuinely undercut most competitors on cash pay.
Compounded medications are not FDA-approved. Worth knowing before you click anything.
The clinical trial data HealthRX cites is real: SURMOUNT-1 showed roughly 21% body weight reduction with tirzepatide over 72 weeks; STEP 1 showed about 15% with semaglutide over 68 weeks. HealthRX doesn’t make those results its own claim, which is the honest way to present them.
Best for: Cash-pay patients who want low entry pricing, fast setup, and a verifiable pharmacy.
2. FormBlends
FormBlends is worth a spot here for a specific kind of buyer. It also operates under a clinician-supervised compounded GLP-1 model, dispensed through an FDA-registered 503A pharmacy. The differentiator is transparency around lab testing: FormBlends publishes per-product purity data including HPLC purity percentages, mass spec identity confirmation, and endotoxin/sterility results. Most GLP-1 telehealth brands don’t show you that paperwork at all.
Pricing is higher. A vial of semaglutide costs roughly $299, with tirzepatide coming in at about $349. Ships to 47 states, not all 50. It also offers a wider peptide catalog covering recovery, cognition, and longevity compounds under the same clinical model, which is unusual for this category.
Best for: Anyone who wants published lab verification before injecting a compounded product, or who wants GLP-1 treatment alongside other peptide protocols from one provider.
3. Mochi Health
Mochi uses board-certified obesity-medicine physicians, which is a real credential distinction. Not just any telehealth GP. Monthly costs start at roughly $99 for semaglutide and around $199 for tirzepatide. The monitoring is more hands-on than many budget options. Small but genuine.
4. Hims & Hers
After the March 2026 Novo Nordisk settlement, Hims & Hers moved away from compounded GLP-1s and toward branded medications. Injectable Wegovy is listed around $299 a month on their platform, oral semaglutide around $249, Zepbound around $399. With insurance and a savings card, some patients pay next to nothing. Big platform, established support infrastructure.
5. Ro Body
Ro’s first-month membership fee is low, around $39, with ongoing costs between $74 and $149 per month. Medications are billed separately. They have a prior-authorization team, which matters if you want to try getting insurance to cover branded meds. Not the cheapest cash-pay option but a solid full-service program.
6. Form Health
Premium tier. About $299 a month plus labs and medication costs. You get an MD and a registered dietitian on the same team. If you want structured, intensive coaching alongside your prescription, this is closer to a clinical weight-loss program than a simple telehealth consult.
7. PlushCare
PlushCare’s membership is about $19.99 a month. Same-day visits are often available. They prescribe branded medications and work with insurance. No compounded options, but if you want a fast appointment and a real prior-auth attempt, it’s a lean option.
8. Found
Found charges around $99 a month for the platform plus medication costs on top. Coaching is built into the program. Not the most medically intensive setup, but it’s structured for people who want accountability tools alongside the prescription.
9. Henry Meds
Cash-pay compounded GLP-1s, first month around $179 to $249, with shipping typically 24 to 72 hours. Lighter on monitoring than Mochi. Fast and affordable. Good if you want minimal friction and already have a clear sense of what you’re doing.
A Quick Note on the 2026 Market
The FDA sent warning letters to more than 30 compounding and telehealth firms in early 2026. The compounded GLP-1 space is worth entering carefully. Ask any provider which pharmacy is filling your order and whether it holds 503A status.
Common Questions
Does it matter whether my GLP-1 telehealth doctor has an obesity-medicine board certification?
Yes, it does. A board-certified obesity-medicine physician has completed additional training specifically in weight physiology, not just general prescribing. Mochi Health is the clearest example of this in the list above. Most other platforms use general practitioners or internists, which is legal but not the same level of specialization.
What should I actually ask a provider about their compounding pharmacy before I order?
Ask for the pharmacy’s name, its 503A registration number, and whether it carries LegitScript certification. HealthRX names Manifest Pharmacy outright and publishes a LegitScript cert number. FormBlends publishes HPLC purity data. If a provider refuses to name the pharmacy or can’t produce documentation, that is a real warning sign.
After the March 2026 Novo Nordisk settlement, can I still get compounded semaglutide legally?
The legal picture shifted but didn’t close entirely. Some 503A pharmacies can still compound for individual patients under specific conditions. The settlement primarily affected large-scale commercial compounders. Programs like HealthRX and Henry Meds continued operating, though the regulatory environment is tighter than it was in 2024 and 2025.
Is the roughly 15 to 21 percent weight loss from clinical trials realistic for a telehealth patient?
Probably not for most people. The STEP 1 and SURMOUNT-1 trials used closely monitored research populations with consistent adherence over 68 to 72 weeks. Real-world results in telehealth settings tend to be lower, partly because adherence drops and partly because dose titration is less supervised. Treat those numbers as a ceiling, not a promise.
Which programs on this list are worth it if insurance is covering part of the cost?
Hims & Hers and PlushCare are the strongest fits for insurance-assisted patients. Both prescribe branded medications, Wegovy and Zepbound specifically, and both have prior-authorization support built into their workflows. Ro Body also has a dedicated prior-auth team. Cash-pay compounding programs like HealthRX or Henry Meds become less relevant once insurance enters the picture.
Sources
- FDA compounding guidance and 2026 warning letter notices: fda.gov
- SURMOUNT-1 trial (tirzepatide): New England Journal of Medicine, 2022
- STEP 1 trial (semaglutide): New England Journal of Medicine, 2021
- Novo Nordisk settlement reporting: Reuters, March 2026
- LegitScript pharmacy certification database: legitscript.com
